racemetirosine has been researched along with Colorectal Neoplasms in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomiyoshi, K | 1 |
| Inoue, T | 1 |
| Higuchi, T | 1 |
| Ahmed, K | 1 |
| Sarwar, M | 1 |
| Alyafei, S | 1 |
| Zhang, H | 1 |
| Matsubara, K | 1 |
| Endo, K | 1 |
| Yang, D | 1 |
1 other study available for racemetirosine and Colorectal Neoplasms
| Article | Year |
|---|---|
Metabolic studies of [18F-alpha-methyl]tyrosine in mice bearing colorectal carcinoma LS-180.
Topics: alpha-Methyltyrosine; Animals; Autoradiography; Brain; Chromatography, High Pressure Liquid; Chromat | 1999 |